the impact of idh mutated clones in npm1 aml
Published 2 years ago • 355 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
2:08
the impact of idh mutations on the outcomes of patients with aml & inhibitors under investigation
-
2:53
the prognostic impact of idh mutations and the role of idh inhibitors in mds
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
1:14
the impact of idh mutations in mds & evaluating the role of idh inhibitors
-
4:41
acute myeloid leukemia survival rate and outlook
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
4:34
the genetics of acute myeloid leukemia (aml)
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
1:56
mrd negativity in npm1-mutated aml: the influence of co-occurring mutations and flag-ida induction
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
1:31
five-year follow-up of olutasidenib for idh1-mutated r/r aml
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
1:56
the efficacy of olutasidenib in patients with r/r idh-mutant aml
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
2:58
feasibility and safety of early discharge in nd aml following intensive induction therapy
-
1:02
the impact of sequencing in aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:51
idh1/2 inhibitors for upfront aml therapy and transfusion independence
-
1:42
aml: new targeted inhibitors as single agents?
-
3:02
the effects of maintenance therapy on real-world outcomes for patients with ndmm